Francine Mary Benes, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Schizophrenia | 81 | 2021 | 6983 | 4.690 |
Why?
|
| gamma-Aminobutyric Acid | 38 | 2015 | 1141 | 4.650 |
Why?
|
| Glutamate Decarboxylase | 20 | 2017 | 239 | 3.790 |
Why?
|
| Hippocampus | 42 | 2018 | 3785 | 3.640 |
Why?
|
| Bipolar Disorder | 34 | 2018 | 5130 | 2.500 |
Why?
|
| Interneurons | 19 | 2018 | 591 | 2.210 |
Why?
|
| Gyrus Cinguli | 24 | 2008 | 1135 | 2.120 |
Why?
|
| Amygdala | 14 | 2012 | 1380 | 1.690 |
Why?
|
| Prefrontal Cortex | 18 | 2018 | 2238 | 1.640 |
Why?
|
| Pyramidal Cells | 17 | 2014 | 367 | 1.280 |
Why?
|
| Neurons | 35 | 2018 | 9514 | 1.110 |
Why?
|
| Dopamine | 15 | 2009 | 1592 | 1.090 |
Why?
|
| Histone Deacetylase 1 | 2 | 2017 | 133 | 1.040 |
Why?
|
| Neural Pathways | 22 | 2017 | 3117 | 0.900 |
Why?
|
| Receptors, Kainic Acid | 3 | 2012 | 91 | 0.850 |
Why?
|
| Postmortem Changes | 7 | 2016 | 119 | 0.740 |
Why?
|
| Receptors, Dopamine D1 | 5 | 2004 | 277 | 0.710 |
Why?
|
| Limbic System | 7 | 2006 | 424 | 0.710 |
Why?
|
| Rats, Sprague-Dawley | 18 | 2017 | 8128 | 0.700 |
Why?
|
| Rats | 43 | 2018 | 23760 | 0.700 |
Why?
|
| CA2 Region, Hippocampal | 2 | 2017 | 20 | 0.690 |
Why?
|
| Picrotoxin | 7 | 2012 | 61 | 0.690 |
Why?
|
| GABA Antagonists | 5 | 2009 | 119 | 0.680 |
Why?
|
| Nerve Net | 8 | 2021 | 2352 | 0.650 |
Why?
|
| Models, Neurological | 8 | 2015 | 1776 | 0.640 |
Why?
|
| Frontal Lobe | 12 | 2014 | 1426 | 0.640 |
Why?
|
| Isoenzymes | 8 | 2007 | 1688 | 0.630 |
Why?
|
| Cerebral Cortex | 23 | 2010 | 5812 | 0.610 |
Why?
|
| Adaptor Proteins, Signal Transducing | 3 | 2017 | 2909 | 0.580 |
Why?
|
| CA3 Region, Hippocampal | 1 | 2017 | 54 | 0.570 |
Why?
|
| Cell Count | 15 | 2007 | 1832 | 0.550 |
Why?
|
| Receptors, GABA-A | 8 | 2009 | 625 | 0.510 |
Why?
|
| Receptors, N-Methyl-D-Aspartate | 4 | 2008 | 903 | 0.500 |
Why?
|
| Dendrites | 9 | 2018 | 472 | 0.490 |
Why?
|
| Receptors, GABA | 6 | 2006 | 312 | 0.480 |
Why?
|
| DNA Fragmentation | 2 | 2007 | 240 | 0.480 |
Why?
|
| Gene Expression Regulation | 10 | 2021 | 11928 | 0.470 |
Why?
|
| Gene Expression Profiling | 9 | 2016 | 9538 | 0.450 |
Why?
|
| Haloperidol | 6 | 2014 | 394 | 0.450 |
Why?
|
| Glutamic Acid | 6 | 2009 | 1191 | 0.450 |
Why?
|
| Diagnosis | 1 | 2014 | 156 | 0.440 |
Why?
|
| Nuclear Proteins | 3 | 2017 | 5804 | 0.440 |
Why?
|
| Disease Models, Animal | 15 | 2018 | 18349 | 0.430 |
Why?
|
| Myelin Sheath | 4 | 2004 | 652 | 0.430 |
Why?
|
| Dendritic Spines | 1 | 2014 | 245 | 0.420 |
Why?
|
| Serotonin | 3 | 2005 | 1043 | 0.410 |
Why?
|
| DNA Repair | 3 | 2010 | 2050 | 0.410 |
Why?
|
| Brain | 22 | 2018 | 27360 | 0.410 |
Why?
|
| Raphe Nuclei | 2 | 2005 | 104 | 0.390 |
Why?
|
| Schizophrenic Psychology | 7 | 1997 | 1649 | 0.370 |
Why?
|
| Neuroglia | 7 | 2005 | 960 | 0.370 |
Why?
|
| Synapses | 10 | 2008 | 1765 | 0.360 |
Why?
|
| Nerve Fibers | 4 | 1999 | 709 | 0.350 |
Why?
|
| Axons | 9 | 1994 | 1677 | 0.340 |
Why?
|
| Apoptosis | 5 | 2008 | 9523 | 0.330 |
Why?
|
| Microfilament Proteins | 1 | 2015 | 1133 | 0.330 |
Why?
|
| Neuronal Plasticity | 5 | 2009 | 1448 | 0.330 |
Why?
|
| Nerve Fibers, Myelinated | 2 | 2012 | 952 | 0.320 |
Why?
|
| Tyrosine 3-Monooxygenase | 3 | 1999 | 367 | 0.310 |
Why?
|
| Animals | 60 | 2018 | 169246 | 0.310 |
Why?
|
| Gene Dosage | 2 | 2013 | 1219 | 0.310 |
Why?
|
| Receptors, Nicotinic | 1 | 2012 | 494 | 0.310 |
Why?
|
| Nerve Tissue Proteins | 5 | 2021 | 4413 | 0.310 |
Why?
|
| Artifacts | 1 | 2017 | 1926 | 0.310 |
Why?
|
| Antipsychotic Agents | 10 | 2015 | 3081 | 0.300 |
Why?
|
| RNA, Messenger | 14 | 2017 | 12800 | 0.300 |
Why?
|
| Molecular Chaperones | 3 | 2017 | 762 | 0.280 |
Why?
|
| Presynaptic Terminals | 4 | 2004 | 302 | 0.280 |
Why?
|
| Epigenesis, Genetic | 2 | 2018 | 3833 | 0.280 |
Why?
|
| Cell Cycle | 3 | 2010 | 2932 | 0.280 |
Why?
|
| Efferent Pathways | 1 | 2007 | 165 | 0.280 |
Why?
|
| Tissue Banks | 2 | 2010 | 183 | 0.280 |
Why?
|
| Infusion Pumps, Implantable | 1 | 2007 | 158 | 0.270 |
Why?
|
| Electrophysiological Phenomena | 1 | 2008 | 309 | 0.270 |
Why?
|
| Infusion Pumps | 1 | 2007 | 163 | 0.270 |
Why?
|
| Entorhinal Cortex | 2 | 2000 | 287 | 0.270 |
Why?
|
| Receptors, Glutamate | 2 | 2017 | 229 | 0.260 |
Why?
|
| Cerebral Ventricles | 5 | 2013 | 550 | 0.250 |
Why?
|
| Receptors, Neurotransmitter | 2 | 2008 | 172 | 0.250 |
Why?
|
| Nervous System Diseases | 3 | 2012 | 1662 | 0.250 |
Why?
|
| Ethology | 1 | 2004 | 7 | 0.240 |
Why?
|
| Co-Repressor Proteins | 2 | 2016 | 190 | 0.240 |
Why?
|
| Biogenic Monoamines | 1 | 2004 | 50 | 0.240 |
Why?
|
| Chromosomes, Human, Pair 11 | 1 | 2006 | 411 | 0.240 |
Why?
|
| Intracellular Signaling Peptides and Proteins | 1 | 2015 | 2892 | 0.240 |
Why?
|
| DNA Methylation | 2 | 2018 | 4428 | 0.230 |
Why?
|
| Humans | 106 | 2021 | 768166 | 0.220 |
Why?
|
| Aging | 6 | 2007 | 8744 | 0.220 |
Why?
|
| Electrophysiology | 4 | 2012 | 1266 | 0.210 |
Why?
|
| Psychotic Disorders | 6 | 2010 | 3276 | 0.200 |
Why?
|
| Benzazepines | 3 | 2000 | 308 | 0.200 |
Why?
|
| Nerve Growth Factors | 1 | 2005 | 564 | 0.200 |
Why?
|
| Mental Disorders | 7 | 2016 | 6874 | 0.200 |
Why?
|
| Human Experimentation | 1 | 2003 | 125 | 0.200 |
Why?
|
| Catheterization | 1 | 2007 | 1430 | 0.200 |
Why?
|
| Immunohistochemistry | 11 | 2012 | 11095 | 0.200 |
Why?
|
| Dopamine Antagonists | 2 | 2000 | 284 | 0.190 |
Why?
|
| CpG Islands | 2 | 2018 | 1208 | 0.190 |
Why?
|
| Receptors, Dopamine D2 | 2 | 1995 | 471 | 0.190 |
Why?
|
| Male | 59 | 2018 | 364719 | 0.190 |
Why?
|
| Autoradiography | 6 | 2008 | 727 | 0.190 |
Why?
|
| Demyelinating Diseases | 1 | 2004 | 358 | 0.180 |
Why?
|
| Neuropharmacology | 1 | 2001 | 19 | 0.180 |
Why?
|
| Glutamates | 2 | 1992 | 385 | 0.180 |
Why?
|
| Temporal Lobe | 4 | 2018 | 1726 | 0.180 |
Why?
|
| Parvalbumins | 2 | 2017 | 256 | 0.170 |
Why?
|
| GTP-Binding Proteins | 1 | 2004 | 948 | 0.170 |
Why?
|
| Corticosterone | 1 | 2001 | 301 | 0.170 |
Why?
|
| Models, Biological | 3 | 2012 | 9495 | 0.170 |
Why?
|
| Oligodendroglia | 1 | 2004 | 540 | 0.170 |
Why?
|
| Clozapine | 2 | 2014 | 509 | 0.170 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2003 | 373 | 0.170 |
Why?
|
| Imaging, Three-Dimensional | 2 | 2005 | 4063 | 0.160 |
Why?
|
| Gene Expression | 7 | 2018 | 7598 | 0.160 |
Why?
|
| In Situ Hybridization | 4 | 2004 | 1903 | 0.150 |
Why?
|
| Lysine | 1 | 2002 | 1000 | 0.150 |
Why?
|
| Membrane Proteins | 1 | 2015 | 7876 | 0.150 |
Why?
|
| Rats, Inbred Strains | 7 | 1994 | 2087 | 0.150 |
Why?
|
| Alzheimer Disease | 7 | 2004 | 8759 | 0.140 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 5 | 2009 | 4580 | 0.140 |
Why?
|
| Case-Control Studies | 7 | 2015 | 22291 | 0.140 |
Why?
|
| Analysis of Variance | 3 | 2015 | 6229 | 0.140 |
Why?
|
| Neocortex | 1 | 2001 | 416 | 0.140 |
Why?
|
| Receptors, G-Protein-Coupled | 1 | 2004 | 1247 | 0.140 |
Why?
|
| Cytochromes c1 | 1 | 2016 | 8 | 0.140 |
Why?
|
| Neurons, Afferent | 3 | 2012 | 498 | 0.130 |
Why?
|
| Informed Consent | 1 | 2003 | 1010 | 0.130 |
Why?
|
| Atrophy | 6 | 2014 | 1646 | 0.130 |
Why?
|
| Phenotype | 5 | 2013 | 16726 | 0.130 |
Why?
|
| Aged | 31 | 2018 | 171504 | 0.130 |
Why?
|
| Middle Aged | 33 | 2018 | 223492 | 0.130 |
Why?
|
| MSX1 Transcription Factor | 1 | 2015 | 53 | 0.130 |
Why?
|
| Endodeoxyribonucleases | 2 | 2009 | 165 | 0.120 |
Why?
|
| Aged, 80 and over | 13 | 2018 | 59629 | 0.120 |
Why?
|
| Cyclin D2 | 1 | 2015 | 98 | 0.120 |
Why?
|
| Down-Regulation | 3 | 2007 | 2937 | 0.120 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 4 | 2009 | 3800 | 0.120 |
Why?
|
| Varicose Veins | 1 | 1996 | 158 | 0.120 |
Why?
|
| Action Potentials | 2 | 2015 | 1838 | 0.120 |
Why?
|
| Adult | 33 | 2016 | 223646 | 0.120 |
Why?
|
| Substantia Nigra | 2 | 2008 | 346 | 0.120 |
Why?
|
| Nerve Endings | 1 | 1994 | 103 | 0.120 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2021 | 1656 | 0.110 |
Why?
|
| Female | 36 | 2018 | 397192 | 0.110 |
Why?
|
| Cadaver | 3 | 2006 | 1363 | 0.110 |
Why?
|
| Statistics as Topic | 2 | 2015 | 2357 | 0.110 |
Why?
|
| Cell Communication | 2 | 2005 | 1660 | 0.100 |
Why?
|
| Long-Term Potentiation | 2 | 2006 | 290 | 0.100 |
Why?
|
| Microscopy, Electron | 6 | 2002 | 2560 | 0.100 |
Why?
|
| Amyloid | 4 | 1991 | 854 | 0.100 |
Why?
|
| Biogenic Amines | 1 | 1991 | 53 | 0.100 |
Why?
|
| RNA | 2 | 2016 | 2720 | 0.100 |
Why?
|
| Neurodegenerative Diseases | 2 | 2016 | 1095 | 0.100 |
Why?
|
| Microdissection | 2 | 2008 | 150 | 0.100 |
Why?
|
| Kainic Acid | 1 | 2012 | 203 | 0.100 |
Why?
|
| Oscillometry | 1 | 2012 | 151 | 0.090 |
Why?
|
| Autopsy | 5 | 2010 | 1011 | 0.090 |
Why?
|
| Dentate Gyrus | 2 | 2004 | 165 | 0.090 |
Why?
|
| Receptors, Cholinergic | 2 | 2005 | 244 | 0.090 |
Why?
|
| Anti-Inflammatory Agents | 1 | 2001 | 1805 | 0.090 |
Why?
|
| Intermediate Filament Proteins | 3 | 1988 | 261 | 0.090 |
Why?
|
| Arousal | 1 | 1997 | 1180 | 0.090 |
Why?
|
| Signal Transduction | 4 | 2018 | 23645 | 0.090 |
Why?
|
| Reference Values | 4 | 2006 | 4938 | 0.090 |
Why?
|
| Brain Damage, Chronic | 1 | 1991 | 265 | 0.090 |
Why?
|
| Cell Line, Transformed | 1 | 2012 | 866 | 0.090 |
Why?
|
| Thalamus | 1 | 1997 | 1047 | 0.090 |
Why?
|
| Cerebellum | 1 | 2018 | 1522 | 0.090 |
Why?
|
| Neurofibrils | 2 | 1990 | 75 | 0.090 |
Why?
|
| Neuropsychiatry | 1 | 2010 | 76 | 0.080 |
Why?
|
| Genome | 1 | 2018 | 1754 | 0.080 |
Why?
|
| Platelet-Derived Growth Factor | 1 | 2012 | 617 | 0.080 |
Why?
|
| Patch-Clamp Techniques | 1 | 2012 | 927 | 0.080 |
Why?
|
| Inhibitory Postsynaptic Potentials | 1 | 2009 | 62 | 0.080 |
Why?
|
| Blotting, Western | 2 | 2016 | 5027 | 0.080 |
Why?
|
| Neurotransmitter Agents | 3 | 2008 | 663 | 0.080 |
Why?
|
| GABA-A Receptor Antagonists | 1 | 2008 | 59 | 0.080 |
Why?
|
| Fluorescent Antibody Technique | 4 | 1996 | 2474 | 0.080 |
Why?
|
| Brain Mapping | 3 | 2012 | 6685 | 0.080 |
Why?
|
| Immunoenzyme Techniques | 4 | 1996 | 1703 | 0.080 |
Why?
|
| Animals, Newborn | 3 | 2005 | 2678 | 0.080 |
Why?
|
| Chromatography, High Pressure Liquid | 1 | 2012 | 1534 | 0.080 |
Why?
|
| Brain-Derived Neurotrophic Factor | 1 | 2012 | 605 | 0.070 |
Why?
|
| Microscopy, Fluorescence | 2 | 1993 | 2633 | 0.070 |
Why?
|
| Cerebral Ventriculography | 2 | 1990 | 44 | 0.070 |
Why?
|
| Rosaniline Dyes | 1 | 2007 | 50 | 0.070 |
Why?
|
| Research Design | 2 | 1998 | 6211 | 0.070 |
Why?
|
| Biological Specimen Banks | 1 | 2013 | 788 | 0.070 |
Why?
|
| Lasers | 1 | 1991 | 952 | 0.070 |
Why?
|
| Disaster Planning | 1 | 2013 | 560 | 0.070 |
Why?
|
| Weaning | 2 | 1998 | 102 | 0.070 |
Why?
|
| Biomedical Research | 1 | 2003 | 3463 | 0.070 |
Why?
|
| Tritium | 2 | 1998 | 707 | 0.070 |
Why?
|
| Cohort Studies | 6 | 2018 | 41754 | 0.070 |
Why?
|
| Binding, Competitive | 2 | 1999 | 1142 | 0.070 |
Why?
|
| Neural Inhibition | 2 | 2001 | 588 | 0.070 |
Why?
|
| Hydrocephalus | 1 | 2013 | 768 | 0.070 |
Why?
|
| Image Processing, Computer-Assisted | 5 | 2004 | 9015 | 0.070 |
Why?
|
| Denervation | 2 | 2005 | 265 | 0.070 |
Why?
|
| Receptor, Muscarinic M1 | 1 | 2005 | 25 | 0.060 |
Why?
|
| Genetic Association Studies | 1 | 2015 | 2744 | 0.060 |
Why?
|
| Neurofilament Proteins | 4 | 1991 | 336 | 0.060 |
Why?
|
| Calcium Channels, L-Type | 1 | 2007 | 244 | 0.060 |
Why?
|
| Sympatholytics | 1 | 2005 | 82 | 0.060 |
Why?
|
| Dominance, Cerebral | 1 | 2007 | 623 | 0.060 |
Why?
|
| Receptor, Muscarinic M3 | 1 | 2005 | 37 | 0.060 |
Why?
|
| Transcription, Genetic | 1 | 1999 | 7608 | 0.060 |
Why?
|
| Membrane Potentials | 1 | 2008 | 1090 | 0.060 |
Why?
|
| Glial Fibrillary Acidic Protein | 1 | 2007 | 563 | 0.060 |
Why?
|
| Oxidopamine | 1 | 2005 | 169 | 0.060 |
Why?
|
| Zoology | 1 | 2004 | 1 | 0.060 |
Why?
|
| Age Factors | 6 | 2003 | 18412 | 0.060 |
Why?
|
| Geese | 1 | 2004 | 19 | 0.060 |
Why?
|
| Digoxigenin | 1 | 2004 | 26 | 0.060 |
Why?
|
| Growth Cones | 1 | 2005 | 117 | 0.060 |
Why?
|
| Muscimol | 2 | 1996 | 70 | 0.060 |
Why?
|
| History, 20th Century | 2 | 2004 | 2766 | 0.060 |
Why?
|
| Cells, Cultured | 3 | 2016 | 19015 | 0.060 |
Why?
|
| Protein Subunits | 1 | 2007 | 943 | 0.060 |
Why?
|
| Cell Size | 2 | 1997 | 626 | 0.060 |
Why?
|
| Cholecystokinin | 1 | 2004 | 115 | 0.050 |
Why?
|
| Cell Line | 1 | 2017 | 15597 | 0.050 |
Why?
|
| Commodification | 1 | 2003 | 3 | 0.050 |
Why?
|
| Synaptic Transmission | 2 | 2002 | 1177 | 0.050 |
Why?
|
| Duty to Recontact | 1 | 2003 | 19 | 0.050 |
Why?
|
| Polymorphism, Single-Stranded Conformational | 1 | 2003 | 325 | 0.050 |
Why?
|
| Adolescent | 10 | 2016 | 89169 | 0.050 |
Why?
|
| Diagnostic Imaging | 3 | 2009 | 3533 | 0.050 |
Why?
|
| Staining and Labeling | 3 | 1992 | 1081 | 0.050 |
Why?
|
| Tomography, X-Ray Computed | 8 | 1998 | 20760 | 0.050 |
Why?
|
| Comorbidity | 2 | 2014 | 10590 | 0.050 |
Why?
|
| Fluorescence Resonance Energy Transfer | 1 | 2004 | 414 | 0.050 |
Why?
|
| In Situ Nick-End Labeling | 1 | 2003 | 611 | 0.050 |
Why?
|
| Tissue Distribution | 2 | 1998 | 2300 | 0.050 |
Why?
|
| Genetic Research | 1 | 2003 | 173 | 0.050 |
Why?
|
| Synaptic Vesicles | 2 | 1985 | 190 | 0.050 |
Why?
|
| DNA Primers | 1 | 2006 | 2828 | 0.050 |
Why?
|
| Injections | 1 | 2004 | 840 | 0.050 |
Why?
|
| Stress, Psychological | 1 | 1997 | 4530 | 0.050 |
Why?
|
| Brain Diseases | 1 | 2010 | 1554 | 0.050 |
Why?
|
| Amyloidosis | 1 | 1989 | 878 | 0.050 |
Why?
|
| Sickness Impact Profile | 1 | 2002 | 299 | 0.050 |
Why?
|
| Culture Techniques | 1 | 2001 | 530 | 0.050 |
Why?
|
| Nerve Tissue | 1 | 2001 | 78 | 0.040 |
Why?
|
| Industry | 1 | 2003 | 362 | 0.040 |
Why?
|
| Nobel Prize | 1 | 2001 | 46 | 0.040 |
Why?
|
| Functional Laterality | 1 | 2007 | 2264 | 0.040 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 2004 | 10760 | 0.040 |
Why?
|
| Ownership | 1 | 2003 | 338 | 0.040 |
Why?
|
| Receptors, Cell Surface | 1 | 1989 | 2819 | 0.040 |
Why?
|
| Neuropil | 1 | 1999 | 31 | 0.040 |
Why?
|
| Histocytochemistry | 3 | 1996 | 699 | 0.040 |
Why?
|
| Rats, Inbred F344 | 1 | 2001 | 826 | 0.040 |
Why?
|
| Haplotypes | 1 | 2006 | 2722 | 0.040 |
Why?
|
| Poisson Distribution | 1 | 2001 | 506 | 0.040 |
Why?
|
| Antioxidants | 1 | 2007 | 1673 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 1999 | 285 | 0.040 |
Why?
|
| Afferent Pathways | 1 | 2000 | 304 | 0.040 |
Why?
|
| Neuromuscular Junction | 2 | 1998 | 407 | 0.040 |
Why?
|
| Corpus Striatum | 1 | 1985 | 1224 | 0.040 |
Why?
|
| Monomeric Clathrin Assembly Proteins | 1 | 1998 | 24 | 0.040 |
Why?
|
| Receptor Aggregation | 1 | 1998 | 72 | 0.040 |
Why?
|
| Coated Vesicles | 1 | 1998 | 23 | 0.040 |
Why?
|
| Pyridinium Compounds | 1 | 1978 | 81 | 0.040 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1978 | 156 | 0.040 |
Why?
|
| Neurosciences | 1 | 2003 | 383 | 0.040 |
Why?
|
| Sweden | 1 | 2001 | 1382 | 0.040 |
Why?
|
| Radioligand Assay | 1 | 1998 | 366 | 0.040 |
Why?
|
| Chromosome Mapping | 1 | 2006 | 4620 | 0.040 |
Why?
|
| Commerce | 1 | 2003 | 612 | 0.040 |
Why?
|
| Terminology as Topic | 1 | 2004 | 1542 | 0.030 |
Why?
|
| Archaeology | 1 | 1997 | 38 | 0.030 |
Why?
|
| Computers | 2 | 1991 | 592 | 0.030 |
Why?
|
| Ventral Tegmental Area | 1 | 1998 | 135 | 0.030 |
Why?
|
| Receptors, Dopamine | 1 | 1998 | 293 | 0.030 |
Why?
|
| Cell Differentiation | 3 | 2005 | 11669 | 0.030 |
Why?
|
| Prenatal Exposure Delayed Effects | 2 | 2001 | 2538 | 0.030 |
Why?
|
| Mitochondria | 3 | 2008 | 3681 | 0.030 |
Why?
|
| Acetylcholine | 1 | 1978 | 629 | 0.030 |
Why?
|
| Coloring Agents | 1 | 1998 | 565 | 0.030 |
Why?
|
| Oxidative Stress | 1 | 2007 | 3139 | 0.030 |
Why?
|
| Biopsy | 1 | 2007 | 6793 | 0.030 |
Why?
|
| Regression Analysis | 2 | 1996 | 6340 | 0.030 |
Why?
|
| Time Factors | 5 | 2007 | 40218 | 0.030 |
Why?
|
| Mianserin | 1 | 1995 | 51 | 0.030 |
Why?
|
| Base Sequence | 1 | 2006 | 12421 | 0.030 |
Why?
|
| Depressive Disorder | 2 | 1989 | 3721 | 0.030 |
Why?
|
| Infant, Newborn | 4 | 1998 | 26422 | 0.030 |
Why?
|
| Neurofibrillary Tangles | 1 | 1997 | 459 | 0.030 |
Why?
|
| Cytoskeleton | 2 | 2008 | 1179 | 0.030 |
Why?
|
| History, 21st Century | 1 | 2001 | 1573 | 0.030 |
Why?
|
| Parkinson Disease | 1 | 2008 | 2893 | 0.030 |
Why?
|
| Sex Factors | 2 | 2001 | 10632 | 0.030 |
Why?
|
| Molecular Weight | 2 | 1988 | 2173 | 0.030 |
Why?
|
| Acyltransferases | 2 | 1973 | 306 | 0.030 |
Why?
|
| RNA Stability | 1 | 2016 | 319 | 0.030 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2002 | 984 | 0.030 |
Why?
|
| Spiperone | 1 | 1993 | 31 | 0.030 |
Why?
|
| Linear Models | 1 | 2004 | 5884 | 0.030 |
Why?
|
| Protein Binding | 1 | 2006 | 9343 | 0.030 |
Why?
|
| Child | 5 | 2007 | 80917 | 0.030 |
Why?
|
| Protein Isoforms | 1 | 2018 | 1715 | 0.030 |
Why?
|
| Stress, Physiological | 1 | 2001 | 1408 | 0.030 |
Why?
|
| Fear | 1 | 2002 | 1495 | 0.030 |
Why?
|
| Tissue Donors | 1 | 2003 | 2381 | 0.030 |
Why?
|
| Video Recording | 1 | 1998 | 976 | 0.030 |
Why?
|
| Infant | 4 | 1998 | 36535 | 0.030 |
Why?
|
| Physical Chromosome Mapping | 1 | 2013 | 183 | 0.030 |
Why?
|
| Microscopy, Confocal | 2 | 1998 | 1972 | 0.030 |
Why?
|
| Singapore | 1 | 2013 | 300 | 0.030 |
Why?
|
| Psychotropic Drugs | 1 | 2018 | 881 | 0.030 |
Why?
|
| Antibodies | 1 | 2000 | 2421 | 0.030 |
Why?
|
| Phospholipids | 2 | 1973 | 787 | 0.030 |
Why?
|
| Immunologic Techniques | 1 | 1992 | 213 | 0.030 |
Why?
|
| Phenothiazines | 1 | 1992 | 60 | 0.020 |
Why?
|
| Iproniazid | 1 | 1991 | 8 | 0.020 |
Why?
|
| Bicuculline | 1 | 1992 | 96 | 0.020 |
Why?
|
| Child, Preschool | 4 | 1998 | 42669 | 0.020 |
Why?
|
| Social Environment | 1 | 1997 | 1012 | 0.020 |
Why?
|
| Family | 1 | 2003 | 3209 | 0.020 |
Why?
|
| Trigeminal Nerve | 1 | 1973 | 248 | 0.020 |
Why?
|
| Brain Stem | 1 | 1977 | 859 | 0.020 |
Why?
|
| Young Adult | 2 | 2016 | 60066 | 0.020 |
Why?
|
| Confidence Intervals | 1 | 1997 | 2923 | 0.020 |
Why?
|
| Monoamine Oxidase Inhibitors | 1 | 1991 | 153 | 0.020 |
Why?
|
| Penetrance | 1 | 2013 | 385 | 0.020 |
Why?
|
| Transcription Factors | 1 | 2010 | 12168 | 0.020 |
Why?
|
| Cell Movement | 2 | 1993 | 5210 | 0.020 |
Why?
|
| Chi-Square Distribution | 1 | 1997 | 3436 | 0.020 |
Why?
|
| Binding Sites | 1 | 1999 | 6020 | 0.020 |
Why?
|
| Emotions | 1 | 2002 | 2767 | 0.020 |
Why?
|
| Sensitivity and Specificity | 1 | 2006 | 14729 | 0.020 |
Why?
|
| Antibodies, Monoclonal | 5 | 1998 | 9263 | 0.020 |
Why?
|
| Cognition Disorders | 2 | 2009 | 3980 | 0.020 |
Why?
|
| RNA Probes | 1 | 1990 | 111 | 0.020 |
Why?
|
| Chromosomes | 1 | 2013 | 578 | 0.020 |
Why?
|
| Benzothiazoles | 1 | 1991 | 248 | 0.020 |
Why?
|
| Affective Disorders, Psychotic | 1 | 1991 | 187 | 0.020 |
Why?
|
| Peptide Fragments | 1 | 2002 | 5151 | 0.020 |
Why?
|
| Cognition | 2 | 2008 | 7073 | 0.020 |
Why?
|
| Organ Size | 1 | 1994 | 2267 | 0.020 |
Why?
|
| Phosphoproteins | 1 | 1998 | 2451 | 0.020 |
Why?
|
| Motor Cortex | 2 | 1987 | 1013 | 0.020 |
Why?
|
| Nerve Degeneration | 1 | 1993 | 749 | 0.020 |
Why?
|
| Efficiency, Organizational | 1 | 2013 | 697 | 0.020 |
Why?
|
| Methaqualone | 1 | 1988 | 4 | 0.020 |
Why?
|
| Age of Onset | 1 | 1995 | 3347 | 0.020 |
Why?
|
| Tryptophan Oxygenase | 1 | 1968 | 19 | 0.020 |
Why?
|
| Radiation Effects | 1 | 1968 | 73 | 0.020 |
Why?
|
| Homozygote | 1 | 2013 | 1779 | 0.020 |
Why?
|
| Dementia | 1 | 1983 | 2740 | 0.020 |
Why?
|
| Cost-Benefit Analysis | 1 | 2001 | 5536 | 0.020 |
Why?
|
| N-Methylaspartate | 1 | 2008 | 231 | 0.020 |
Why?
|
| Biotechnology | 1 | 1989 | 283 | 0.020 |
Why?
|
| Up-Regulation | 1 | 1996 | 4146 | 0.020 |
Why?
|
| Schizotypal Personality Disorder | 1 | 2009 | 289 | 0.020 |
Why?
|
| Pregnancy | 2 | 2001 | 30256 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 13014 | 0.020 |
Why?
|
| Organ Preservation | 1 | 2010 | 393 | 0.020 |
Why?
|
| Brain Chemistry | 1 | 2010 | 958 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 2010 | 794 | 0.020 |
Why?
|
| Genetic Markers | 1 | 2013 | 2603 | 0.020 |
Why?
|
| Evaluation Studies as Topic | 1 | 1988 | 1627 | 0.020 |
Why?
|
| Heterozygote | 1 | 2013 | 2798 | 0.020 |
Why?
|
| Brain Neoplasms | 1 | 2007 | 9118 | 0.020 |
Why?
|
| Specimen Handling | 1 | 2010 | 708 | 0.020 |
Why?
|
| Fibroblasts | 1 | 2016 | 4176 | 0.020 |
Why?
|
| United States | 4 | 2013 | 73039 | 0.020 |
Why?
|
| Immune Sera | 1 | 1985 | 605 | 0.010 |
Why?
|
| Odds Ratio | 1 | 1997 | 9669 | 0.010 |
Why?
|
| Quantitative Trait Loci | 1 | 2013 | 2131 | 0.010 |
Why?
|
| Ion Channels | 1 | 2008 | 1043 | 0.010 |
Why?
|
| Early Diagnosis | 1 | 2009 | 1194 | 0.010 |
Why?
|
| Thiazoles | 1 | 1991 | 1542 | 0.010 |
Why?
|
| Chronic Disease | 1 | 1998 | 9384 | 0.010 |
Why?
|
| Algorithms | 1 | 2004 | 14164 | 0.010 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 1 | 1985 | 1730 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 1998 | 4978 | 0.010 |
Why?
|
| Fluorescent Dyes | 1 | 1991 | 1930 | 0.010 |
Why?
|
| Child Development | 1 | 1994 | 2330 | 0.010 |
Why?
|
| Probability | 1 | 1987 | 2479 | 0.010 |
Why?
|
| Dexamethasone | 1 | 1989 | 1965 | 0.010 |
Why?
|
| Genome-Wide Association Study | 1 | 2021 | 12795 | 0.010 |
Why?
|
| Epitopes | 1 | 1988 | 2528 | 0.010 |
Why?
|
| Carrier Proteins | 1 | 1995 | 4937 | 0.010 |
Why?
|
| Hydrocortisone | 1 | 1989 | 1841 | 0.010 |
Why?
|
| France | 1 | 2002 | 497 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 1988 | 36743 | 0.010 |
Why?
|
| Quality of Life | 1 | 2002 | 13490 | 0.010 |
Why?
|
| Mice, Transgenic | 1 | 2013 | 9561 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2016 | 15454 | 0.010 |
Why?
|
| Ubiquitin-Protein Ligases | 1 | 2008 | 1901 | 0.010 |
Why?
|
| Motivation | 1 | 1989 | 2020 | 0.010 |
Why?
|
| Rana pipiens | 1 | 1978 | 64 | 0.010 |
Why?
|
| Cell Survival | 1 | 2008 | 5777 | 0.010 |
Why?
|
| Anura | 1 | 1978 | 79 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6316 | 0.010 |
Why?
|
| Amyloid beta-Peptides | 2 | 1990 | 3914 | 0.010 |
Why?
|
| Synaptic Membranes | 1 | 1998 | 89 | 0.010 |
Why?
|
| Social Behavior | 1 | 1985 | 1147 | 0.010 |
Why?
|
| Attention | 1 | 1989 | 2424 | 0.010 |
Why?
|
| Dilatation, Pathologic | 2 | 1990 | 527 | 0.010 |
Why?
|
| Image Enhancement | 1 | 1988 | 2880 | 0.010 |
Why?
|
| Prognosis | 1 | 1998 | 30010 | 0.010 |
Why?
|
| Epitope Mapping | 1 | 1998 | 301 | 0.010 |
Why?
|
| Liver | 1 | 1972 | 7577 | 0.010 |
Why?
|
| Homeostasis | 1 | 2008 | 3348 | 0.010 |
Why?
|
| Clathrin | 1 | 1998 | 258 | 0.010 |
Why?
|
| Movement | 1 | 1983 | 1490 | 0.010 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 1998 | 301 | 0.010 |
Why?
|
| Chick Embryo | 1 | 1998 | 975 | 0.010 |
Why?
|
| Risk | 1 | 2008 | 9613 | 0.010 |
Why?
|
| Mice, Inbred Strains | 1 | 1978 | 1765 | 0.010 |
Why?
|
| Twins | 1 | 1997 | 341 | 0.010 |
Why?
|
| Substance-Related Disorders | 2 | 2009 | 4423 | 0.010 |
Why?
|
| Chickens | 1 | 1977 | 845 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2002 | 2741 | 0.010 |
Why?
|
| Education | 1 | 1997 | 533 | 0.010 |
Why?
|
| Cholesterol | 2 | 1973 | 2914 | 0.010 |
Why?
|
| Mice | 3 | 2013 | 82029 | 0.010 |
Why?
|
| Biological Transport | 1 | 1998 | 2085 | 0.010 |
Why?
|
| Isoflurophate | 1 | 1972 | 27 | 0.010 |
Why?
|
| Rest | 1 | 1978 | 948 | 0.010 |
Why?
|
| Microsomes | 1 | 1973 | 252 | 0.010 |
Why?
|
| Electric Stimulation | 1 | 1978 | 1741 | 0.010 |
Why?
|
| Palmitic Acids | 1 | 1972 | 53 | 0.010 |
Why?
|
| Glycerides | 1 | 1972 | 67 | 0.010 |
Why?
|
| Coenzyme A | 1 | 1972 | 39 | 0.010 |
Why?
|
| Glycerophosphates | 1 | 1972 | 51 | 0.010 |
Why?
|
| Methods | 1 | 1972 | 1066 | 0.010 |
Why?
|
| Schwann Cells | 1 | 1973 | 196 | 0.010 |
Why?
|
| Cattle | 1 | 1998 | 3819 | 0.010 |
Why?
|
| Carbon Isotopes | 1 | 1972 | 458 | 0.010 |
Why?
|
| Inclusion Bodies | 1 | 1973 | 278 | 0.010 |
Why?
|
| Golgi Apparatus | 1 | 1973 | 406 | 0.010 |
Why?
|
| Fatty Acids, Nonesterified | 1 | 1972 | 394 | 0.010 |
Why?
|
| Endoplasmic Reticulum | 1 | 1977 | 1133 | 0.010 |
Why?
|
| Environment | 1 | 1997 | 1121 | 0.010 |
Why?
|
| Medical History Taking | 1 | 1974 | 779 | 0.010 |
Why?
|
| Copper | 1 | 1972 | 368 | 0.010 |
Why?
|
| Risk Factors | 1 | 1997 | 74944 | 0.010 |
Why?
|
| Mice, Inbred BALB C | 1 | 1998 | 6231 | 0.000 |
Why?
|
| Eye Diseases | 1 | 1974 | 660 | 0.000 |
Why?
|
| Length of Stay | 1 | 1982 | 6498 | 0.000 |
Why?
|
| Euphoria | 1 | 1988 | 64 | 0.000 |
Why?
|
| Ophthalmology | 1 | 1974 | 560 | 0.000 |
Why?
|
| Enzyme Induction | 1 | 1968 | 455 | 0.000 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2009 | 18065 | 0.000 |
Why?
|
| Tryptophan | 1 | 1968 | 482 | 0.000 |
Why?
|
| Models, Chemical | 1 | 1968 | 611 | 0.000 |
Why?
|
| Social Behavior Disorders | 1 | 1985 | 100 | 0.000 |
Why?
|
| Lipid Metabolism | 1 | 1972 | 1904 | 0.000 |
Why?
|
| Cell Membrane | 1 | 1973 | 3655 | 0.000 |
Why?
|
| Lipids | 1 | 1972 | 3343 | 0.000 |
Why?
|
| Hypnotics and Sedatives | 1 | 1988 | 1191 | 0.000 |
Why?
|
| Parietal Lobe | 1 | 1985 | 866 | 0.000 |
Why?
|
| Neuropsychological Tests | 1 | 1989 | 7140 | 0.000 |
Why?
|
| Activities of Daily Living | 1 | 1985 | 2430 | 0.000 |
Why?
|
| Hospitals, University | 1 | 1974 | 570 | 0.000 |
Why?
|
| Information Systems | 1 | 1974 | 400 | 0.000 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 1974 | 392 | 0.000 |
Why?
|
| Germany | 1 | 1974 | 883 | 0.000 |
Why?
|
| Follow-Up Studies | 1 | 1990 | 39348 | 0.000 |
Why?
|
| Pattern Recognition, Automated | 1 | 1974 | 993 | 0.000 |
Why?
|
| Retrospective Studies | 1 | 1990 | 81762 | 0.000 |
Why?
|